99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Female
Interventions: DRUG: ADAPT6-SPECT
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences
Collaborators: Uppsala University